These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 38113856)

  • 21. Surgical Interventions for Organ and Limb Ischemia Associated With Primary and Secondary Antiphospholipid Antibody Syndrome With Arterial Involvement.
    Hinojosa CA; Anaya-Ayala JE; Bermudez-Serrato K; García-Alva R; Laparra-Escareno H; Torres-Machorro A; Lizola R
    Vasc Endovascular Surg; 2017 Nov; 51(8):550-554. PubMed ID: 28920529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral artery dissection secondary to antiphospholipid syndrome: A report of two cases and a literature review.
    Iseki T; Yamashita Y; Ueno Y; Hira K; Miyamoto N; Yamashiro K; Tsunemi T; Teranishi K; Yatomi K; Nakajima S; Kijima C; Oishi H; Hattori N
    Lupus; 2021 Jan; 30(1):118-124. PubMed ID: 33016197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature.
    Tenti S; Cheleschi S; Guidelli GM; Galeazzi M; Fioravanti A
    Autoimmun Rev; 2016 Mar; 15(3):226-35. PubMed ID: 26656906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children.
    Amoura Z; Bader-Meunier B; Bal Dit Sollier C; Belot A; Benhamou Y; Bezanahary H; Cohen F; Costedoat-Chalumeau N; Darnige L; Drouet L; Elefant E; Harroche A; Lambert M; Martin T; Martin-Toutain I; Mathian A; Mekinian A; Pineton De Chambrun M; de Pontual L; Wahl D; Yelnik C; Zuily S;
    Rev Med Interne; 2023 Sep; 44(9):495-520. PubMed ID: 37735010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous immunoglobulin therapy of antiphospholipid syndrome.
    Sherer Y; Levy Y; Shoenfeld Y
    Rheumatology (Oxford); 2000 Apr; 39(4):421-6. PubMed ID: 10817776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological markers of high risk of thrombotic recurrence in patients with antiphospholipid syndrome: A literature review.
    Lambert M; Brodovitch A; Mège JL; Bertin D; Bardin N
    Autoimmun Rev; 2024 Jun; 23(6):103585. PubMed ID: 39094811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic risk factors in thrombotic primary antiphospholipid syndrome: A systematic review with bioinformatic analyses.
    Islam MA; Khandker SS; Alam F; Kamal MA; Gan SH
    Autoimmun Rev; 2018 Mar; 17(3):226-243. PubMed ID: 29355608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome.
    Anunciación-Llunell A; Muñoz C; Roggenbuck D; Frasca S; Pardos-Gea J; Esteve-Valverde E; Alijotas-Reig J; Miró-Mur F
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of obstetric antiphospholipid syndrome.
    de Jesus GR; dos Santos FC; Oliveira CS; Mendes-Silva W; de Jesus NR; Levy RA
    Curr Rheumatol Rep; 2012 Feb; 14(1):79-86. PubMed ID: 22105547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexistent antiphospholipid syndrome and myeloproliferative neoplasm.
    Sayar Z; Nallamilli S; Efthymiou M; Lambert J; Cohen H
    Lupus; 2021 Aug; 30(9):1502-1508. PubMed ID: 34192956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.
    de Jesús GR; Sciascia S; Andrade D; Barbhaiya M; Tektonidou M; Banzato A; Pengo V; Ji L; Meroni PL; Ugarte A; Cohen H; Branch DW; Andreoli L; Belmont HM; Fortin PR; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Nascimento IS; Rosa R; Erkan D; Levy RA;
    BJOG; 2019 Apr; 126(5):656-661. PubMed ID: 30222236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic review.
    Cheng C; Cheng GY; Denas G; Pengo V
    Blood Rev; 2021 Jul; 48():100788. PubMed ID: 33341301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe thrombotic events associated with pre-procedural interruption of anticoagulation in systemic lupus erythematosus with secondary antiphospholipid syndrome: Cases and literature review.
    Anderson M; Belmont HM
    Lupus; 2022 Feb; 31(2):261-267. PubMed ID: 35041558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus on the Long-term Adverse Cardiovascular Outcomes in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
    Bundhun PK; Boodhoo KD; Long MY; Chen MH
    Medicine (Baltimore); 2016 Mar; 95(12):e3200. PubMed ID: 27015221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal involvement in antiphospholipid syndrome.
    de Azevedo FVA; Maia DG; de Carvalho JF; Rodrigues CEM
    Rheumatol Int; 2018 Oct; 38(10):1777-1789. PubMed ID: 29730854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis.
    Urban ML; Bettiol A; Mattioli I; Emmi G; Di Scala G; Avagliano L; Lombardi N; Crescioli G; Virgili G; Serena C; Mecacci F; Ravaldi C; Vannacci A; Silvestri E; Prisco D
    Intern Emerg Med; 2021 Aug; 16(5):1357-1367. PubMed ID: 33475972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches.
    Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Collantes E; Aguirre MA; Perez-Sanchez C
    Front Immunol; 2019; 10():764. PubMed ID: 31040845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of clinical and serological features in thrombotic antiphospholipid syndrome patients, with and without associated systemic lupus erythematosus, followed for up to 42 years: A single centre retrospective study.
    Mittal P; Pacheco M; Trives-Folguera L; Rua J; Tohidi-Esfahani I; Cohen H; Efthymiou M; Isenberg D
    Lupus; 2024 Sep; 33(10):1082-1088. PubMed ID: 39092568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.